Efficacy and safety of vilazodone 20 mg and 40 mg in major depressive disorder: A randomized, double-blind, placebo- and active-controlled trial

被引：0
|
作者：
Gommoll, C. [1 ]
Mathews, M. [1 ]
Chen, D. [1 ]
Nunez, R. [1 ]
Khan, A. [1 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2014年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-23-011
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
    Mathews, Maju
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Khan, Arif
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (02) : 67 - 74
  • [2] Efficacy and safety of vilazodone 20mg and 40mg in major depressive disorder (MDD): a randomised, double-blind, placebo-and active-controlled trial
    Khan, A.
    Gommoll, C.
    Mathews, M.
    Chen, D.
    Nunez, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S386 - S387
  • [3] Efficacy and Safety of Vilazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Pomara, Nunzio
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Mathews, Maju
    Croft, Harry A.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S378 - S379
  • [4] Efficacy and Safety of Vilazodone in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Croft, Harry A.
    Pomara, Nunzio
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Mathews, Maju
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : E1291 - E1298
  • [5] Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial
    Loebel, Antony
    Cucchiaro, Josephine
    Sarma, Kaushik
    Xu, Lei
    Hsu, Chuanchieh
    Kalali, Amir H.
    Pikalov, Andrei
    Potkin, Steven G.
    SCHIZOPHRENIA RESEARCH, 2013, 145 (1-3) : 101 - 109
  • [6] A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive Disorder
    Jacobsen, Paula L.
    Mahableshwarkar, Atul R.
    Serenko, Michael
    Chan, Serena
    Trivedi, Madhukar H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (05) : 575 - 582
  • [7] Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Rickels, Karl
    Athanasiou, Maria
    Robinson, Donald S.
    Gibertini, Michael
    Whalen, Heidi
    Reed, Carol R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (03) : 326 - 333
  • [8] A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of MIN-117 in Patients With Major Depressive Disorder
    Davidson, Michael
    Staner, Corinne
    Saoud, Jay
    Noel, Nadine
    Werner, Sandra
    Luthringer, Elisabeth
    Reilly, Joe
    Luthringer, Remy
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S370 - S370
  • [9] Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Asnis, Gregory M.
    Bose, Anjana
    Gommoll, Carl P.
    Chen, Changzheng
    Greenberg, William M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (03) : 242 - 248
  • [10] Efficacy and safety of topical diclofenac/menthol gel for ankle sprain: A randomized, double-blind, placebo- and active-controlled trial
    Lai, Pamela M.
    Collaku, Agron
    Reed, Kenneth
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2017, 45 (02) : 647 - 661
12345